HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-APR-16 5J7S TITLE CRYSTAL STRUCTURE OF SM1-71 BOUND TO TAK1-TAB1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7/TGF-BETA- COMPND 3 ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1 CHIMERA; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP O43318 RESIDUES 31-303, Q15750 RESIDUES 468-504; COMPND 6 SYNONYM: TRANSFORMING GROWTH FACTOR-BETA-ACTIVATED KINASE 1,TGF-BETA- COMPND 7 ACTIVATED KINASE 1,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7- COMPND 8 INTERACTING PROTEIN 1,TGF-BETA-ACTIVATED KINASE 1-BINDING PROTEIN 1, COMPND 9 TAK1-BINDING PROTEIN 1; COMPND 10 EC: 2.7.11.25; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP3K7, TAK1, TAB1, MAP3K7IP1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7/TGF-BETA-ACTIVATED KEYWDS 2 KINASE 1 AND MAP3K7-BINDING PROTEIN 1, TRANSFERASE-TRANSFERASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.GURBANI,K.D.WESTOVER REVDAT 4 27-SEP-23 5J7S 1 REMARK REVDAT 3 08-JAN-20 5J7S 1 REMARK REVDAT 2 27-SEP-17 5J7S 1 REMARK REVDAT 1 15-FEB-17 5J7S 0 JRNL AUTH L.TAN,D.GURBANI,E.L.WEISBERG,J.C.HUNTER,L.LI,D.S.JONES, JRNL AUTH 2 S.B.FICARRO,S.MOWAFY,C.P.TAM,S.RAO,G.DU,J.D.GRIFFIN, JRNL AUTH 3 P.K.SORGER,J.A.MARTO,K.D.WESTOVER,N.S.GRAY JRNL TITL STRUCTURE-GUIDED DEVELOPMENT OF COVALENT TAK1 INHIBITORS. JRNL REF BIOORG. MED. CHEM. V. 25 838 2017 JRNL REFN ESSN 1464-3391 JRNL PMID 28011204 JRNL DOI 10.1016/J.BMC.2016.11.035 REMARK 2 REMARK 2 RESOLUTION. 2.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 22973 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1150 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.5094 - 4.7351 1.00 2979 157 0.2106 0.2134 REMARK 3 2 4.7351 - 3.7588 1.00 2871 150 0.1957 0.2175 REMARK 3 3 3.7588 - 3.2838 1.00 2826 149 0.2196 0.2127 REMARK 3 4 3.2838 - 2.9836 1.00 2812 149 0.2360 0.2909 REMARK 3 5 2.9836 - 2.7697 1.00 2783 146 0.2473 0.2402 REMARK 3 6 2.7697 - 2.6064 0.96 2672 142 0.2784 0.3309 REMARK 3 7 2.6064 - 2.4759 0.92 2568 136 0.3294 0.3455 REMARK 3 8 2.4759 - 2.3681 0.83 2312 121 0.3825 0.3865 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2329 REMARK 3 ANGLE : 0.846 3158 REMARK 3 CHIRALITY : 0.046 330 REMARK 3 PLANARITY : 0.006 399 REMARK 3 DIHEDRAL : 11.080 1381 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J7S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220087. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97932 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK HIGH-RESOLUTION REMARK 200 DOUBLE-CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23015 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.368 REMARK 200 RESOLUTION RANGE LOW (A) : 49.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.48600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.880 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4O91 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.75M NACITRATE, 0.1M TRIS-HCL, 0.2M REMARK 280 NACL, PH 7.0, 5MM ADENOSINE; ADENOSINE BOUND TAK1-TAB1 CRYSTALS REMARK 280 ARE BACKSOAKED WITH INHIBITOR., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.11700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.03000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 73.40700 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.11700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.03000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 73.40700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.11700 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 67.03000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 73.40700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.11700 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 67.03000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.40700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 46 REMARK 465 PHE A 47 REMARK 465 GLN A 64 REMARK 465 ILE A 65 REMARK 465 GLU A 66 REMARK 465 SER A 67 REMARK 465 GLU A 68 REMARK 465 SER A 69 REMARK 465 GLU A 70 REMARK 465 ARG A 71 REMARK 465 GLY A 94 REMARK 465 ALA A 95 REMARK 465 CYS A 96 REMARK 465 GLY A 177 REMARK 465 THR A 178 REMARK 465 ALA A 179 REMARK 465 CYS A 180 REMARK 465 ASP A 181 REMARK 465 ILE A 182 REMARK 465 GLN A 183 REMARK 465 THR A 184 REMARK 465 HIS A 185 REMARK 465 MET A 186 REMARK 465 THR A 187 REMARK 465 ASN A 188 REMARK 465 ASN A 189 REMARK 465 LYS A 190 REMARK 465 GLU A 497 REMARK 465 GLN A 498 REMARK 465 SER A 499 REMARK 465 VAL A 500 REMARK 465 VAL A 501 REMARK 465 THR A 502 REMARK 465 ALA A 503 REMARK 465 PRO A 504 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 33 -37.15 74.09 REMARK 500 GLU A 39 -66.67 -127.86 REMARK 500 VAL A 42 -87.98 -108.95 REMARK 500 ARG A 155 -52.96 74.94 REMARK 500 ASP A 156 54.38 -103.82 REMARK 500 ASN A 205 152.81 -45.80 REMARK 500 SER A 207 -164.34 -102.15 REMARK 500 GLN A 299 -19.21 -149.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6H3 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5J7R RELATED DB: PDB REMARK 900 RELATED ID: 5J8I RELATED DB: PDB DBREF 5J7S A 31 303 UNP O43318 M3K7_HUMAN 31 303 DBREF 5J7S A 468 504 UNP Q15750 TAB1_HUMAN 468 504 SEQADV 5J7S SER A 27 UNP O43318 EXPRESSION TAG SEQADV 5J7S LEU A 28 UNP O43318 EXPRESSION TAG SEQADV 5J7S HIS A 29 UNP O43318 EXPRESSION TAG SEQADV 5J7S MET A 30 UNP O43318 EXPRESSION TAG SEQRES 1 A 314 SER LEU HIS MET ILE ASP TYR LYS GLU ILE GLU VAL GLU SEQRES 2 A 314 GLU VAL VAL GLY ARG GLY ALA PHE GLY VAL VAL CYS LYS SEQRES 3 A 314 ALA LYS TRP ARG ALA LYS ASP VAL ALA ILE LYS GLN ILE SEQRES 4 A 314 GLU SER GLU SER GLU ARG LYS ALA PHE ILE VAL GLU LEU SEQRES 5 A 314 ARG GLN LEU SER ARG VAL ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 314 LEU TYR GLY ALA CYS LEU ASN PRO VAL CYS LEU VAL MET SEQRES 7 A 314 GLU TYR ALA GLU GLY GLY SER LEU TYR ASN VAL LEU HIS SEQRES 8 A 314 GLY ALA GLU PRO LEU PRO TYR TYR THR ALA ALA HIS ALA SEQRES 9 A 314 MET SER TRP CYS LEU GLN CYS SER GLN GLY VAL ALA TYR SEQRES 10 A 314 LEU HIS SER MET GLN PRO LYS ALA LEU ILE HIS ARG ASP SEQRES 11 A 314 LEU LYS PRO PRO ASN LEU LEU LEU VAL ALA GLY GLY THR SEQRES 12 A 314 VAL LEU LYS ILE CYS ASP PHE GLY THR ALA CYS ASP ILE SEQRES 13 A 314 GLN THR HIS MET THR ASN ASN LYS GLY SER ALA ALA TRP SEQRES 14 A 314 MET ALA PRO GLU VAL PHE GLU GLY SER ASN TYR SER GLU SEQRES 15 A 314 LYS CYS ASP VAL PHE SER TRP GLY ILE ILE LEU TRP GLU SEQRES 16 A 314 VAL ILE THR ARG ARG LYS PRO PHE ASP GLU ILE GLY GLY SEQRES 17 A 314 PRO ALA PHE ARG ILE MET TRP ALA VAL HIS ASN GLY THR SEQRES 18 A 314 ARG PRO PRO LEU ILE LYS ASN LEU PRO LYS PRO ILE GLU SEQRES 19 A 314 SER LEU MET THR ARG CYS TRP SER LYS ASP PRO SER GLN SEQRES 20 A 314 ARG PRO SER MET GLU GLU ILE VAL LYS ILE MET THR HIS SEQRES 21 A 314 LEU MET ARG TYR PHE PRO GLY ALA ASP GLU PRO LEU GLN SEQRES 22 A 314 TYR PRO CYS GLN HIS SER LEU PRO PRO GLY GLU ASP GLY SEQRES 23 A 314 ARG VAL GLU PRO TYR VAL ASP PHE ALA GLU PHE TYR ARG SEQRES 24 A 314 LEU TRP SER VAL ASP HIS GLY GLU GLN SER VAL VAL THR SEQRES 25 A 314 ALA PRO HET 6H3 A 601 33 HETNAM 6H3 N-{2-[(5-CHLORO-2-{[4-(4-METHYLPIPERAZIN-1-YL) HETNAM 2 6H3 PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENYL}PROPANAMIDE FORMUL 2 6H3 C24 H28 CL N7 O HELIX 1 AA1 PHE A 74 SER A 82 1 9 HELIX 2 AA2 SER A 111 GLY A 118 1 8 HELIX 3 AA3 THR A 126 SER A 146 1 21 HELIX 4 AA4 LYS A 158 PRO A 160 5 3 HELIX 5 AA5 SER A 192 MET A 196 5 5 HELIX 6 AA6 ALA A 197 GLU A 202 1 6 HELIX 7 AA7 GLU A 208 ARG A 225 1 18 HELIX 8 AA8 PRO A 235 ASN A 245 1 11 HELIX 9 AA9 PRO A 256 TRP A 267 1 12 HELIX 10 AB1 ASP A 270 ARG A 274 5 5 HELIX 11 AB2 SER A 276 MET A 288 1 13 HELIX 12 AB3 ARG A 289 PHE A 291 5 3 HELIX 13 AB4 PHE A 484 HIS A 495 1 12 SHEET 1 AA1 5 ILE A 36 VAL A 41 0 SHEET 2 AA1 5 CYS A 51 TRP A 55 -1 O LYS A 54 N GLU A 37 SHEET 3 AA1 5 ASP A 59 ILE A 62 -1 O VAL A 60 N ALA A 53 SHEET 4 AA1 5 VAL A 103 GLU A 105 -1 O MET A 104 N ALA A 61 SHEET 5 AA1 5 LEU A 92 TYR A 93 -1 N TYR A 93 O VAL A 103 SHEET 1 AA2 2 LEU A 122 PRO A 123 0 SHEET 2 AA2 2 PRO A 301 CYS A 302 -1 O CYS A 302 N LEU A 122 SHEET 1 AA3 2 LEU A 162 VAL A 165 0 SHEET 2 AA3 2 VAL A 170 ILE A 173 -1 O LYS A 172 N LEU A 163 SHEET 1 AA4 2 LEU A 251 ILE A 252 0 SHEET 2 AA4 2 ARG A 477 VAL A 478 1 O VAL A 478 N LEU A 251 LINK SG CYS A 174 C31 6H3 A 601 1555 1555 1.62 CISPEP 1 ASN A 98 PRO A 99 0 -1.49 CISPEP 2 GLU A 120 PRO A 121 0 0.72 CISPEP 3 GLN A 148 PRO A 149 0 2.55 SITE 1 AC1 9 VAL A 42 ALA A 61 MET A 104 GLU A 105 SITE 2 AC1 9 TYR A 106 ALA A 107 LEU A 163 CYS A 174 SITE 3 AC1 9 PHE A 176 CRYST1 58.234 134.060 146.814 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017172 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007459 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006811 0.00000